484 related articles for article (PubMed ID: 17107381)
1. Effect of small interfering RNA on the expression of connective tissue growth factor and type I and III collagen in skin fibroblasts of patients with systemic sclerosis.
Xiao R; Liu FY; Luo JY; Yang XJ; Wen HQ; Su YW; Yan KL; Li YP; Liang YS
Br J Dermatol; 2006 Dec; 155(6):1145-53. PubMed ID: 17107381
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of collagen production with small interfering RNA of SPARC in cultured fibroblasts from the skin of patients with scleroderma.
Zhou X; Tan FK; Guo X; Arnett FC
Arthritis Rheum; 2006 Aug; 54(8):2626-31. PubMed ID: 16871529
[TBL] [Abstract][Full Text] [Related]
3. Connective tissue growth factor siRNA modulates mRNA levels for a subset of molecules in normal and TGF-beta 1-stimulated porcine skin fibroblasts.
Wang JF; Olson ME; Ma L; Brigstock DR; Hart DA
Wound Repair Regen; 2004; 12(2):205-16. PubMed ID: 15086772
[TBL] [Abstract][Full Text] [Related]
4. Induction of matrix metalloproteinase-1 by small interfering RNA targeting connective tissue growth factor in dermal fibroblasts from patients with systemic sclerosis.
Ishibuchi H; Abe M; Yokoyama Y; Ishikawa O
Exp Dermatol; 2010 Aug; 19(8):e111-6. PubMed ID: 20653770
[TBL] [Abstract][Full Text] [Related]
5. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.
Chujo S; Shirasaki F; Kawara S; Inagaki Y; Kinbara T; Inaoki M; Takigawa M; Takehara K
J Cell Physiol; 2005 May; 203(2):447-56. PubMed ID: 15605379
[TBL] [Abstract][Full Text] [Related]
6. SPARC, an upstream regulator of connective tissue growth factor in response to transforming growth factor beta stimulation.
Zhou XD; Xiong MM; Tan FK; Guo XJ; Arnett FC
Arthritis Rheum; 2006 Dec; 54(12):3885-9. PubMed ID: 17133596
[TBL] [Abstract][Full Text] [Related]
7. 9-Cis-retinoic acid exhibits antifibrotic activity via the induction of cyclooxygenase-2 expression and prostaglandin E2 production in scleroderma fibroblasts.
Xiao R; Kanekura T; Yoshida N; Higashi Y; Yan KL; Fukushige T; Kanzaki T
Clin Exp Dermatol; 2008 Jul; 33(4):484-90. PubMed ID: 18462443
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of expression of extracellular matrix genes with siRNAs to Sparc and Ctgf in skin fibroblasts of CTGF transgenic mice.
Wang JC; Sonnylal S; Arnett FC; De Crombrugghe B; Zhou X
Int J Immunopathol Pharmacol; 2011; 24(3):595-601. PubMed ID: 21978691
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia induces expression of connective tissue growth factor in scleroderma skin fibroblasts.
Hong KH; Yoo SA; Kang SS; Choi JJ; Kim WU; Cho CS
Clin Exp Immunol; 2006 Nov; 146(2):362-70. PubMed ID: 17034590
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of fibrosis with selective inhibition of c-Abl by siRNA in systemic sclerosis dermal fibroblasts.
Karimizadeh E; Motamed N; Mahmoudi M; Jafarinejad-Farsangi S; Jamshidi A; Faridani H; Gharibdoost F
Arch Dermatol Res; 2015 Mar; 307(2):135-42. PubMed ID: 25527259
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta 2 modulated extracellular matrix component expression in cultured human optic nerve head astrocytes.
Fuchshofer R; Birke M; Welge-Lussen U; Kook D; Lütjen-Drecoll E
Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):568-78. PubMed ID: 15671284
[TBL] [Abstract][Full Text] [Related]
12. Antifibrotic effects of hepatocyte growth factor on scleroderma fibroblasts and analysis of its mechanism.
Sherriff-Tadano R; Ohta A; Morito F; Mitamura M; Haruta Y; Koarada S; Tada Y; Nagasawa K; Ozaki I
Mod Rheumatol; 2006; 16(6):364-71. PubMed ID: 17164998
[TBL] [Abstract][Full Text] [Related]
13. Retinoic acids exhibit anti-fibrotic activity through the inhibition of 5-lipoxygenase expression in scleroderma fibroblasts.
Xiao R; Yoshida N; Higashi Y; Lu QJ; Fukushige T; Kanzaki T; Kanekura T
J Dermatol; 2011 Apr; 38(4):345-53. PubMed ID: 21352343
[TBL] [Abstract][Full Text] [Related]
14. Selective stimulation of collagen synthesis in the presence of costimulatory insulin signaling by connective tissue growth factor in scleroderma fibroblasts.
Gore-Hyer E; Pannu J; Smith EA; Grotendorst G; Trojanowska M
Arthritis Rheum; 2003 Mar; 48(3):798-806. PubMed ID: 12632435
[TBL] [Abstract][Full Text] [Related]
15. Hammerhead ribozyme targeting connective tissue growth factor mRNA blocks transforming growth factor-beta mediated cell proliferation.
Blalock TD; Yuan R; Lewin AS; Schultz GS
Exp Eye Res; 2004 Jun; 78(6):1127-36. PubMed ID: 15109919
[TBL] [Abstract][Full Text] [Related]
16. Role of connective tissue growth factor in the pathogenesis of conjunctival scarring in ocular cicatricial pemphigoid.
Razzaque MS; Foster CS; Ahmed AR
Invest Ophthalmol Vis Sci; 2003 May; 44(5):1998-2003. PubMed ID: 12714635
[TBL] [Abstract][Full Text] [Related]
17. Role of connective tissue growth factor in profibrotic action of transforming growth factor-beta: a potential target for preventing renal fibrosis.
Yokoi H; Sugawara A; Mukoyama M; Mori K; Makino H; Suganami T; Nagae T; Yahata K; Fujinaga Y; Tanaka I; Nakao K
Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S134-8. PubMed ID: 11576939
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta promotes pro-fibrotic behavior by serosal fibroblasts via PKC and ERK1/2 mitogen activated protein kinase cell signaling.
Mulsow JJ; Watson RW; Fitzpatrick JM; O'Connell PR
Ann Surg; 2005 Dec; 242(6):880-7, discussion 887-9. PubMed ID: 16327498
[TBL] [Abstract][Full Text] [Related]
19. siRNA-mediated knockdown of connective tissue growth factor prevents N-nitrosodimethylamine-induced hepatic fibrosis in rats.
George J; Tsutsumi M
Gene Ther; 2007 May; 14(10):790-803. PubMed ID: 17344905
[TBL] [Abstract][Full Text] [Related]
20. CD109, a TGF-β co-receptor, attenuates extracellular matrix production in scleroderma skin fibroblasts.
Man XY; Finnson KW; Baron M; Philip A
Arthritis Res Ther; 2012 Jun; 14(3):R144. PubMed ID: 22694813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
